Adult Vaccines Global Market Overview, Driving Factors, Future Trends, Key Players and Growth Opportunities And Forecast By 2033 | Pfizer Inc., AstraZeneca PLC, Novartis AG, Novavax Inc., Medimmune

The adult vaccines market size has grown strongly in recent years. It will grow from $21.48 billion in 2023 to $23.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing aging population, government vaccination programs, growing awareness of preventive healthcare, vaccine development and innovation, public health campaigns..

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $32.13 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emergence of new infectious threats, increasing focus on immunization registries, rising threat of antimicrobial resistance, global efforts for pandemic preparedness, shift toward personalized vaccines, increased focus on maternal immunization.. Major trends in the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, expanding immunization programs..

Market Overview -
Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases such as influenza, pneumococcal disease, and herpes.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Rising Prevalence Of Contagious Diseases Drives Growth In Adult Vaccine Market
The increasing prevalence of contagious diseases is driving the adult vaccine market forward. Contagious diseases are diseases that spread from person to person. Vaccines help the person to develop immunity against contagious diseases and therefore are a very effective mechanism for fighting infections. For instance, in December 2022, according to the World Health Organization's COVID-19 dashboard, a Switzerland-based public health agency of the United Nations, 655 million people were infected with COVID-19 since the emergence of the virus in 2019. Furthermore, in 2021, according to the global tuberculosis report published by the World Health Organization, a Switzerland-based international public health agency of the United Nations, 1.3 million deaths (Non-HIV) occurred due to TB (Tuberculosis) which was up from 1.2 million in 2019. Therefore, the increasing prevalence of contagious diseases is driving the growth of the adult vaccines market.

Competitive Landscape -
Major companies operating in the adult vaccines market report are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Bharat Biotech, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Protein Sciences Corporation, Takeda Pharmaceutical Company Limited .

Data Trend Platform To Enhance Adult Vaccination Efforts
Product innovations are a key trend gaining popularity in the adult vaccines market. Major companies in the market are introducing innovative products to sustain their position in the market. For instance, in August 2022, GSK, a UK-based biopharma company, and IQVIA, an India-based global provider of advanced analytics, technology solutions, and clinical research services, launched Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide. This resource will provide frequent and relevant data on trends to focus on and enhance public health efforts.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Key Segments -
The adult vaccines market covered in this report is segmented -
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.